Creation Technologies Launches FDA UDI Compliance Program


Reading time ( words)

Creation Technologies, award-winning EMS provider with electronics design, rapid prototyping and manufacturing locations around the globe, has announced its milestone achievement of the USA Food and Drug Administration (FDA) Unique Device Identification (UDI) Compliance for Class I, Class II and Class III medical device labeling across its global operations.

As an established contract design and manufacturing partner for leading medical device OEMs, Creation’s manufacturing facilities are ISO 13485-certified and FDA-registered. With the recent FDA-mandated UDI compliance date of September 24, 2016 for Class II medical devices, Creation has achieved internal compliance with the regulation. Moreover, the company has announced implementation of a proprietary new tool and automated process within its Vision manufacturing execution system and customer portal that enables its customers to obtain real-time data and device tracking information in support of their UDI compliance.

"Creation Technologies is committed to exceeding all patient safety requirements on behalf of our innovative OEM medical customers. Achieving FDA UDI System compliance for all medical device classes in advance of the 2020 deadline demonstrates this commitment. Creation believes integrating critical UDI traceability information into our Vision system adds exceptional value," said Tim Holzschuh, Director of Regulatory & Quality – Creation Design Services. "The medical device industry anticipates that the return on investment for the UDI System will include less reporting of adverse events, faster regulatory submission turn-around times, and more efficient post-market vigilance."

Additional information about the FDA’s Unique Device Identification requirements can be found in UDI Basics and other resources on the FDA’s website.

About Creation Technologies

Medical device and biotechnology companies working with Creation Technologies have scalable options for risk mitigation and rapid growth through the company’s turnkey solutions that include connected device design and development, rapid prototyping, manufacturing, fulfillment and logistics for complex systems, and VAVE and sustaining engineering.

With FDA-registered and ISO 13485-certified manufacturing facilities and design centers across Canada, USA, Mexico and China, Creation Technologies provides real-time visibility and traceability to its medical customers in markets from cardiovascular to urology imaging to radiation oncology.

Share




Suggested Items

Assemblers Play the ‘Revise or Wait’ Game With Designers

06/22/2022 | Nolan Johnson, I-Connect007
Nolan Johnson recently spoke with Duane Benson at Milwaukee Electronics and Screaming Circuits. Duane was pointing out a trend in moving designs into production, which he termed “revise or wait.” This excerpt provides a preview of our exploration of similar topics involving supply chain issues, lead times, and proceeding forward despite the supply challenges.

How Will Emerging Chiplet Technology Affect PCBs?

06/01/2022 | I-Connect007 Editorial Team
In a recent conversation with Ventec’s Alun Morgan, the I-Connect007 Editorial Team discussed, among several topics, semiconductor packaging developments. Industry insiders will know that, when you get Happy Holden and Alun Morgan talking about emerging technology trends, there will be insights shared.

Getting Involved Earlier in the Test Process

04/18/2022 | Andy Shaughnessy, I-Connect007
At SMTA Dallas, Andy Shaughnessy stopped by the booth for The Test Connection, to find out from Bert Horner why the company has evolved into spending more time educating and consulting with their customers when it comes to testing new designs.



Copyright © 2022 I-Connect007. All rights reserved.